Learn / NBIX
NASDAQ: NBIX
Neurocrine Biosciences (NBIX) stock, explained like you're 5
Neurocrine Biosciences trades on the Nasdaq under the ticker NBIX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 14.5 billion dollars.
- Ticker
- NBIX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Large cap, about 14.5 billion dollars
Is Neurocrine Biosciences a small, medium or large cap company?
Yes. Neurocrine Biosciences is a large cap stock. Its market cap, which is the total value of all its shares, is about 14.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Neurocrine Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NBIX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Neurocrine Biosciences, Inc. (NBIX) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- NBIX Stock Slips As $2.9B Soleno Deal Triggers Fresh Drug Safety Warnings (Stocktwits)
- How New CRENESSITY Data At Neurocrine Biosciences Stock Has Changed Its Investment Story (Simply Wall Street)
- JPMorgan reports a passive stake in Neurocrine Biosciences (NBIX) (Stock Titan)
- Neurocrine Biosciences (NBIX) Stock Trades Below Fair Value On Earnings (Yahoo Finance)
Follow NBIX in your daily brief
Each trading day at 5 PM ET we post what happened to Neurocrine Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NBIX
Questions about Neurocrine Biosciences stock
What does Neurocrine Biosciences do?
Neurocrine Biosciences trades on the Nasdaq under the ticker NBIX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 14.5 billion dollars.
What is the ticker symbol for Neurocrine Biosciences?
Neurocrine Biosciences trades under the ticker NBIX on the Nasdaq.
What is Neurocrine Biosciences's market cap?
Neurocrine Biosciences is a large cap stock with a market cap of about 14.5 billion dollars.
How does Neurocrine Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NBIX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NBIX stock every day?
Add NBIX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.